The Impact of Chronic Kidney Disease and Short-Term Treatment with Rosiglitazone on Plasma Cell-Free DNA Levels

Figure 1

Cell-free DNA levels in patients with renal impairment. (a) Comparison of cfDNA levels by CKD stage (mean and SD are shown). No difference in any group was evident (). (b) Correlation between estimated glomerular filtration rate (calculated using the 4-variable MDRD equation) and cfDNA levels for individual patients is shown (, ).

(a)

(b)